Polyclonal immunoglobulins for COVID-19 pre-exposure prophylaxis in immunocompromised patients

Immunocompromised patients remain at high risk of COVID-19 morbidity and mortality. After recent Omicron sublineages gained full resistance to Evusheld™, they are left without effective pre-exposure prophylaxis. We review here arguments to support the growing role of regular immunoglobulin (IG) infu...

Descripción completa

Detalles Bibliográficos
Autores principales: Focosi, Daniele, Franchini, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9886389/
https://www.ncbi.nlm.nih.gov/pubmed/36759280
http://dx.doi.org/10.1016/j.transci.2023.103648

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9886389/
https://www.ncbi.nlm.nih.gov/pubmed/36759280
http://dx.doi.org/10.1016/j.transci.2023.103648

Ejemplares similares